Foundation Medicine (FMI) Misses Q4 EPS by 9c, Beats on Revenues; Offers FY18 Revenue Outlook Above Consensus
Get Alerts FMI Hot Sheet
Join SI Premium – FREE
Note: EPS may not be comparable
Foundation Medicine (NASDAQ: FMI) reported Q4 EPS of ($1.05), $0.09 worse than the analyst estimate of ($0.96). Revenue for the quarter came in at $48.9 million versus the consensus estimate of $46.21 million.
GUIDANCE:
Foundation Medicine sees FY2018 revenue of $200-220 million, versus the consensus of $194.82 million.
For earnings history and earnings-related data on Foundation Medicine (FMI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walgreens Boots Alliance (WBA) Tops Q2 EPS by 38c, Offers Guidance
- Kodiak Sciences Inc. (KOD) Misses Q4 EPS by 36c
- Walgreens Boots Alliance (WBA) tops Q2 expectations, narrows full-year profit forecast
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!